Literature DB >> 20517722

Protein kinase B (PKB/Akt), a key mediator of the PI3K signaling pathway.

Elisabeth Fayard1, Gongda Xue, Arnaud Parcellier, Lana Bozulic, Brian A Hemmings.   

Abstract

Protein kinase B (PKB/Akt) is a serine/threonine protein kinase that created serious interest when it was revealed as a mediator of the PI3K pathway. It comprises three isoforms that play both unique and redundant roles. Upon binding to phosphatidylinositol-(3,4,5)-trisphosphate (PIP3) generated by PI3K, PKB is phosphorylated by PDK1 at T308. To achieve full kinase activity, PKB needs to be phosphorylated at a second key residue, S473, by members of the PI3K-related kinase family mTORC2 or DNA-PK, depending on the stimulus and the context. Besides, a number of phosphatases and interacting partners have been shown to further modulate its subcellular localization, phosphorylation, and kinase activity. This review aims at illustrating the remarkable complexity in the regulation of PKB signaling downstream of PI3K. Such regulation could be attributed to the specific roles of the PKB isoforms, their expression pattern, subcellular localization, targets, phosphorylation by upstream kinases in a stimulus- and context-dependent manner and by phosphatases, and interaction with binding partners. This allows this key kinase to fulfill physiological functions in numerous processes, including embryonic development, thymocyte development, adipocyte differentiation, glucose homeostasis, and to avoid pathological loss of control such as tumor formation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20517722     DOI: 10.1007/82_2010_58

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  102 in total

1.  mTOR kinase inhibition causes feedback-dependent biphasic regulation of AKT signaling.

Authors:  Vanessa S Rodrik-Outmezguine; Sarat Chandarlapaty; Nen C Pagano; Poulikos I Poulikakos; Maurizio Scaltriti; Elizabeth Moskatel; José Baselga; Sylvie Guichard; Neal Rosen
Journal:  Cancer Discov       Date:  2011-06-17       Impact factor: 39.397

2.  The GRP1 PH domain, like the AKT1 PH domain, possesses a sentry glutamate residue essential for specific targeting to plasma membrane PI(3,4,5)P(3).

Authors:  Carissa Pilling; Kyle E Landgraf; Joseph J Falke
Journal:  Biochemistry       Date:  2011-10-19       Impact factor: 3.162

3.  Akt2: a critical regulator of cardiomyocyte survival and metabolism.

Authors:  Anthony J Muslin
Journal:  Pediatr Cardiol       Date:  2011-01-30       Impact factor: 1.655

4.  Regulation of Na+/H+ exchanger in dendritic cells by Akt2.

Authors:  Madhuri Bhandaru; Wenting Yang; Anand Rotte; Venkanna Pasham; Florian Lang
Journal:  Pflugers Arch       Date:  2011-09-28       Impact factor: 3.657

Review 5.  Histone deacetylase inhibitors in castration-resistant prostate cancer: molecular mechanism of action and recent clinical trials.

Authors:  Dharam Kaushik; Vishal Vashistha; Sudhir Isharwal; Soud A Sediqe; Ming-Fong Lin
Journal:  Ther Adv Urol       Date:  2015-12

6.  Synthetic peptides containing ITIM-like sequences of IREM-1 (CD300F) differentially regulate MyD88 and TRIF-mediated TLR signalling through activation of SHP and/or PI3K.

Authors:  S-M Lee; K Suk; W-H Lee
Journal:  Clin Exp Immunol       Date:  2012-03       Impact factor: 4.330

7.  Identification of P-Rex1 as a novel Rac1-guanine nucleotide exchange factor (GEF) that promotes actin remodeling and GLUT4 protein trafficking in adipocytes.

Authors:  Demis Balamatsias; Anne M Kong; Joanne E Waters; Absorn Sriratana; Rajendra Gurung; Charles G Bailey; John E J Rasko; Tony Tiganis; S Lance Macaulay; Christina A Mitchell
Journal:  J Biol Chem       Date:  2011-10-15       Impact factor: 5.157

8.  Monomethylated-adenines potentiate glucose-induced insulin production and secretion via inhibition of phosphodiesterase activity in rat pancreatic islets.

Authors:  Brandon B Boland; Cristina Alarcón; Almas Ali; Christopher J Rhodes
Journal:  Islets       Date:  2015-09-24       Impact factor: 2.694

9.  Amniotic fluid stem cells prevent β-cell injury.

Authors:  Valentina Villani; Anna Milanesi; Sargis Sedrakyan; Stefano Da Sacco; Susanne Angelow; Maria Teresa Conconi; Rosa Di Liddo; Roger De Filippo; Laura Perin
Journal:  Cytotherapy       Date:  2013-11-07       Impact factor: 5.414

10.  JNK and STAT3 signaling pathways converge on Akt-mediated phosphorylation of EZH2 in bronchial epithelial cells induced by arsenic.

Authors:  Bailing Chen; Jia Liu; Qingshan Chang; Kevin Beezhold; Yongju Lu; Fei Chen
Journal:  Cell Cycle       Date:  2012-12-19       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.